Kenya Liver Disease Market Analysis


  • Type: Therapeutics Area
  • Published : June 2021
  • Region: Africa
  • Country: Kenya
  • Report ID : 4909

  • Format: PPT, PDF

Kenya Liver Diseases Drug Market: Segmented by Disease Type (Chronic Hepatitis, Liver Cirrhosis, Hepatocellular Carcinoma, Non-Alcoholic Fatty Liver Disease), Drug Class (Antiviral drugs, Chemotherapy drugs, Immunosuppressant drugs, Corticosteroids and Others), and Distribution Channels (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others) – Growth, Trends, And Forecasts (2019 – 2028)

SKU: 4909 Categories: ,

Report Overview

The Liver diseases drug market size in Kenya stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period

Hepatic complications due to alcoholism is common in Kenya. There is an unexpected number of cases of chronic aggressive hepatitis and cirrhosis. The prevalence of HBV (Hepatitis B Virus) infection in Kenya is estimated to be between 1% to 5%, although rates among specific high-risk populations (HIV co-infected, drug abusers, jaundiced patients seeking medical care) are much higher. Changing lifestyle such as increasing consumption of alcohol, unhealthy diets have increased the incidences of liver disease. The prevalence of heavy drinking is approximately 12.6% in Kenya. Men are more likely to engage in heavy episodic drinking than women .The highest proportion is reported in the 18–29-year age group.

Market Drivers

Liver Diseases drug market is driven by the high prevalence of liver diseases like Hepatitis and Liver Cirrhosis due to alcoholism in Kenya. According to the latest WHO data published in 2018 Liver Disease Deaths in Kenya reached 2,514 or 0.98% of total deaths. The age adjusted Death Rate is 11.47 per 100,000 of population.

Increase in Government initiatives like screening for hepatitis among high-risk populations and providing clinical care for patients who have tested positive is expected to fuel growth in the hepatitis drug market.

With the increasing prevalence of liver diseases, government and other not-for-profit organizations are playing a crucial role in the rising awareness about liver diseases. Hence all these organizations are found promoting the awareness of the liver-related diseases and support for research and development for the prevention, treatment and cure of liver diseases.

Growing alcohol consumption has increased incidences of liver diseases which would propel the growth of liver disease treatment market in future.

However, the side effects caused by several drug are restraining market growth. The outbreak of COVID-19 has decreased diagnosis, screening and follow-up of patients suffering from hepatitis which has negative outcomes of health in patients with hepatitis.

1. Kenya Liver Diseases Drug Market Overview……………………………………..
A. Market Size
2. Market Growth Drivers………………………………….………………………….
A. Rise in Prevalence of Liver Diseases Infection in Kenya
B. Increase in Government Support for Screening and Clinical Care
C. Increase in the Consumption of Alcohol and Improper Diet
3. Major Liver Diseases………..………………………………………………………
A. Chronic Hepatitis
B. Liver Cirrhosis
C. Hepatocellular Carcinoma
D. Non-Alcoholic Fatty Liver Disease
4. Liver Diseases Drug Market Segmentation…………………………………………
A. Drug Class
I. Antiviral Drugs
II. Chemotherapy Drugs
III. Corticosteroids
IV. Immunosuppressant Drugs
V. Others
B. Distribution Channel
I. Hospital Pharmacies
II. Retail Pharmacies
III. Online Pharmacies
5. Liver Diseases Major Drugs Market Share…………………………….………..
A. Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape…………………………………………………..…………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles…………………………………………………………..…..
A. Merck & Co. Company overview, Product & Services, Strategies & Financials
B. Novartis Company overview, Product & Services, Strategies & Financials
C. GlaxoSmithKline (GSK) Company, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape…………………………….
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth……………………………………………………
A. New Trends and Development of Liver Diseases drug market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Disease Types:

On the basis of disease types, the market for liver diseases drugs can be segmented into Chronic Hepatitis, Liver Cirrhosis, Non-Alcoholic Fatty Liver Disease, Hepatocellular Carcinoma and others.

By Drug Class:

On the basis of drug class, the market can be segmented into antiviral drugs, chemotherapy drugs, corticosteroids, immunosuppressants and others.

The antiviral segment includes Interferons, Nucleoside Reverse Transcriptase Inhibitors (NRTIs). NRTIs constitute entecavir, lamivudine, and telbivudine which are usually taken as a pill once a day for at least a year.

Antiviral drugs segment will dominate the market share due to the high burden of hepatitis infection while reducing the risk of developing cirrhosis and hepatocellular carcinoma.

By Distribution Channel:

On the basis of distribution channel, the market for Liver Diseases drug can be segmented into hospital pharmacies, retail pharmacies, online pharmacies, and others. The hospital and retail segment are expected to dominate the market throughout the forecast period.

 Major Players

The market will be majorly run by Bristol Myers Squibb, Novartis, GlaxoSmithKline with their strong pipeline of drugs for Hepatitis B Virus infection.

Merck & co. is leading the market with its Zepatier drug for Hepatitis C Virus Infection.

Key players such as F. Hoffmann La-Roche and Johnson & Johnson are investigating their candidates for the treatment of chronic Hepatis B Infection.

Hepatis B Vaccine is manufactured by Merck & Co. by the brand name Recombivax HB®.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements